133 related articles for article (PubMed ID: 3580570)
1. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a new human myeloma cell line (U-2030) and selection of a hat-sensitive subline.
Jernberg H; Björklund G; Nilsson K
Int J Cancer; 1987 Jun; 39(6):745-51. PubMed ID: 3583453
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
Eton O; Scheinberg DA; Houghton AN
Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
[TBL] [Abstract][Full Text] [Related]
4. Classification and biological nature of established human hematopoietic cell lines.
Nilsson K; Pontén J
Int J Cancer; 1975 Feb; 15(2):321-41. PubMed ID: 165156
[TBL] [Abstract][Full Text] [Related]
5. Establishment of five human myeloma cell lines.
Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
[TBL] [Abstract][Full Text] [Related]
6. Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change.
Durie BG; Vela E; Baum V; Leibovitz A; Payne CM; Richter LC; Grogan TM; Trent JM
Blood; 1985 Sep; 66(3):548-55. PubMed ID: 3927997
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.
Gazdar AF; Oie HK; Kirsch IR; Hollis GF
Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a permanent human IgA2/kappa myeloma cell line.
Lohmeyer J; Hadam M; Santoso S; Förster W; Schulz A; Pralle H
Br J Haematol; 1988 Jul; 69(3):335-43. PubMed ID: 3136791
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel myeloma cell line, MM.1.
Goldman-Leikin RE; Salwen HR; Herst CV; Variakojis D; Bian ML; Le Beau MM; Selvanayagan P; Marder R; Anderson R; Weitzman S
J Lab Clin Med; 1989 Mar; 113(3):335-45. PubMed ID: 2926241
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Miyamoto K; Hyodo H; Namba M
Int J Cancer; 1982 May; 29(5):495-500. PubMed ID: 7095894
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
[TBL] [Abstract][Full Text] [Related]
13. ARH-77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein-Barr virus.
Drewinko B; Mars W; Minowada J; Burk KH; Trujillo JM
Cancer; 1984 Nov; 54(9):1883-92. PubMed ID: 6090003
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma cell line (FL-18) and Epstein-Barr virus-carrying cell line (FL-18-EB) obtained from a patient with follicular lymphoma: monoclonal derivation and different properties.
Doi S; Ohno H; Tatsumi E; Arita Y; Kamesaki H; Fukuhara S; Nishikori M; Miwa H; Kita K; Hatanaka M
Blood; 1987 Nov; 70(5):1619-23. PubMed ID: 2822175
[TBL] [Abstract][Full Text] [Related]
15. Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.
Tatsumi E; Harada S; Kuszynski C; Volsky D; Minowada J; Purtilo DT
Leuk Res; 1985; 9(2):231-8. PubMed ID: 2985880
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic studies on human myeloma cell lines.
Jernberg H; Zech L; Nilsson K
Int J Cancer; 1987 Dec; 40(6):811-7. PubMed ID: 3500922
[TBL] [Abstract][Full Text] [Related]
17. Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma.
Harashima A; Matsuo Y; Nishizaki C; Kozuka T; Fukuda S; Sezaki T; Orita K
Hum Cell; 2000 Mar; 13(1):43-54. PubMed ID: 10937346
[TBL] [Abstract][Full Text] [Related]
18. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features.
Grogan TM; Durie BG; Lomen C; Spier C; Wirt DP; Nagle R; Wilson GS; Richter L; Vela E; Maxey V
Blood; 1987 Oct; 70(4):932-42. PubMed ID: 3115338
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and biological characterization of two new human plasma cell lines.
Brox LW; Belch A; Pollock E; He XX; De Braekeleer M; Lin CC
Cancer Genet Cytogenet; 1987 Jul; 27(1):135-44. PubMed ID: 3472643
[TBL] [Abstract][Full Text] [Related]
20. Two distinct human myeloma cell lines originating from one patient with myeloma.
Katagiri S; Yonezawa T; Kuyama J; Kanayama Y; Nishida K; Abe T; Tamaki T; Ohnishi M; Tarui S
Int J Cancer; 1985 Aug; 36(2):241-6. PubMed ID: 3926660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
